The lab is committed to advancing care for patients with kidney disease by integrating both quantitative and qualitative research methodologies. Our group employs a multifaceted approach, harnessing the strengths of data science, epidemiology, and social science to drive better outcomes for those affected by kidney disease. The research has been supported by the American Philosophical Society, the American Society of Nephrology Carl W. Gottschalk Research Scholar Grant, and the BU DOM Research Accelerator Program.

Five selected publications:

  1. M. Shohet, L. Stern, N. Nguyen, S.S. Waikar, I.M. Schmidt. Structural and Psychosocial Challenges Among Underserved Patients Receiving Hemodialysis During and Beyond the Coronavirus Disease 2019 Pandemic: A Qualitative Study, Kidney Medicine (2023), DOI: 10.1016/ 74 j.xkme.2023.100717
  2. I.M. Schmidt, M. Shohet, M. Serrano, P. Yadati, H. Menn-Josephy, Titilayo Ilori, N.D. Eneanya, E. Cleveland, S.S. Waikar. Patients’ perspectives on race and the use of race-based algorithms in clinical decision-making: a qualitative study, Journal of General Internal Medicine (2023), PMID: 36811702
  3. I.M. Schmidt, S.S. Mothi, P.C. Wilson, R. Palsson, A. Srivastava, I.F. Onul, Z.A. Kibbelaar, M. Zhuo, A. Amodu, I.E. Stillman, H.G. Rennke, B.D. Humphreys, S.S. Waikar. Circulating Plasma Biomarkers in Biopsy-Confirmed Kidney Disease, Clinical Journal of the American Society of Nephrology (2022), PMID: 34759008.
  4. I.M. Schmidt, M.R. Colona, B.R. Kestenbaum, L.G. Alexopoulos, R. Palsson, A. Srivastava, J. Liu, I.E. Stillman, H.G. Rennke, V.S. Vaidya, H. Wu, B.D. Humphreys, S.S. Waikar. CDH11, SMOC2, and PEDF are promising non-invasive biomarkers of kidney fibrosis. Kidney International (2021), PMID: 34051265
  5. I.M. Schmidt and S.S.Waikar. Separate and Unequal: Race-based Algorithms and Implications for Nephrology. Journal of the American Society of Nephrology (2021), PMID: 3351003